Resistance to doxorubicin treatment is showed to be correlated only with HOTAIR in various tumor pathologies, such as gastric cancer and bladder transient cell carcinoma [140,141], and cells whose down-regulation restores the sensitivity in breast cancer cell lines through PI3K/Akt pathway modulation [142]. This evidence concerns the gene AKT1 and neoplasm.